Featured

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing

Read Article
Clear Filters
Press Release

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Read Article
Press Release

Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats

Read Article
Press Release

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors

Read Article
Press Release

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing

Read Article
Presentation

June 2026 Corporate Investor Presentation Available

Read Article
Press Release

Decoy Therapeutics’ CEO to Participate in hVIVO Capital Markets Day in London

Read Article